Viewing Study NCT06351332


Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2026-01-31 @ 1:29 PM
Study NCT ID: NCT06351332
Status: RECRUITING
Last Update Posted: 2024-12-18
First Post: 2024-04-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: ZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in MTNBC
Sponsor: Filipa Lynce, MD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Breast Cancer Female View
None Triple Negative Breast Cancer View
None Hormone Receptor Negative Malignant Tumor Breast Triple View
None HER2-negative Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast Cancer View
None Breast Cancer Female View
None Triple Negative Breast Cancer View
None Hormone Receptor Negative Malignant Tumor Breast Triple View
None HER2-negative Breast Cancer View